![Ivor Royston](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ivor Royston
Vorstandsvorsitzender bei
Viracta Subsidiary, Inc.
Profil
Ivor Royston was the founder of Hybritech, Inc. (1978), IDEC Pharmaceuticals Corp.
(1986), IDEC Corp.
(United States) (1986), and Forward Ventures Services LLC (1993) with the title of Managing Member at Forward Ventures Services LLC.
Dr. Royston is currently the President, Chief Executive Officer & Director at Viracta Subsidiary, Inc. and the Director at CONNECT.
Former positions include President, Chief Executive Officer & Director at Sunesis Pharmaceuticals, Inc., President & Chief Executive Officer at Sidney Kimmel Cancer Center (1990-2000), Chairman at Morphotek, Inc., Chairman at TargeGen, Inc., Director at Corautus Genetics, Inc., Director at CancerVax Corp., Director at Favrille, Inc. (2000-2009), Independent Director at Biocept, Inc. (2011-2023), Director at MyMedicalRecords, Inc., Independent Director at Syndax Pharmaceuticals, Inc. (2013-2017), Director at Viropro, Inc., Director at Avalon Pharmaceuticals, Inc., Director at Amgen Rockville, Inc., Director at LigoCyte Pharmaceuticals, Inc. (2006-2010), Director-Clinical Immunology at San Diego Cancer Center, Director at HemaQuest Pharmaceuticals, Inc., Director at Altair Therapeutics, Inc., Independent Director at MMRGlobal, Inc. (2013-2016), Director-Clinical Immunology at the University of California, Director at The Life Sciences Foundation, Director at Viracta Therapeutics, Inc. (2022-2025), and Member at the University of California San Diego (1978-1990).
Education includes undergraduate and doctorate degrees from The Johns Hopkins University (1967, 1970).
Aktive Positionen von Ivor Royston
| Unternehmen | Position | Beginn |
|---|---|---|
Viracta Subsidiary, Inc.
 Viracta Subsidiary, Inc. BiotechnologyHealth Technology Develops proprietary viral gene activation therapy to address cancers associated with the epstein-barr virus | Vorstandsvorsitzender | 01.01.2015 |
CONNECT
 CONNECT Miscellaneous Commercial ServicesCommercial Services Offers education, networking and recognitions services | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Ivor Royston
| Unternehmen | Position | Ende |
|---|---|---|
| VIRACTA THERAPEUTICS, INC. | Vorstandsvorsitzender | 19.09.2022 |
| BIOCEPT, INC. | Direktor/Vorstandsmitglied | 13.10.2023 |
| SYNDAX PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.03.2017 |
| MMRGLOBAL, INC. | Direktor/Vorstandsmitglied | 11.08.2016 |
Altair Therapeutics, Inc.
 Altair Therapeutics, Inc. Medical DistributorsDistribution Services Discovers, develops and commercializes antisense drugs | Direktor/Vorstandsmitglied | 09.03.2011 |
Ausbildung von Ivor Royston
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
82
Beziehungen ersten Grades
30
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 30 |
|---|---|
Corautus Genetics, Inc.
 Corautus Genetics, Inc. Pharmaceuticals: MajorHealth Technology Develops gene therapy pharmaceutical products | Health Technology |
Viropro, Inc.
 Viropro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Hybritech, Inc.
 Hybritech, Inc. Miscellaneous Commercial ServicesCommercial Services Provides prostate diagnostic testing services | Commercial Services |
CancerVax Corp.
 CancerVax Corp. Miscellaneous Commercial ServicesCommercial Services Researches and develops products for the prevention, treatment, and control of cancer | Commercial Services |
Favrille, Inc.
 Favrille, Inc. Medical SpecialtiesHealth Technology Researches, develops and commercializes targeted immunotherapies for the treatment of cancer and diseases of the immune system | Health Technology |
Morphotek, Inc.
 Morphotek, Inc. BiotechnologyHealth Technology Develops oncology therapies | Health Technology |
Biocept, Inc.
 Biocept, Inc. Medical/Nursing ServicesHealth Services Develops and performs clinical laboratory tests to detection & analysis of tumor cells and cell-free DNA from cerebrospinal fluid | Health Services |
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics for treatment of solid and hematologic cancers | Health Technology |
TargeGen, Inc.
 TargeGen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures vascular biopharmaceutical products | Health Technology |
MyMedicalRecords, Inc.
 MyMedicalRecords, Inc. Commercial Printing/FormsCommercial Services Provides web-based personal health record and vital document storage solutions | Commercial Services |
Syndax Pharmaceuticals, Inc.
 Syndax Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
IDEC Pharmaceuticals Corp.
 IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes targeted immunotherapies for the treatment of cancer and autoimmune diseases | Health Technology |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avalon Pharmaceuticals, Inc.
 Avalon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics products | Health Technology |
Forward Ventures Services LLC
 Forward Ventures Services LLC Investment ManagersFinance Forward Ventures invests in companies located in the United States. The firm targets operating in the fields on life sciences and bio pharmaceuticals sectors. It provides financing for early stage capital requirements. | Finance |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Develops therapeutics for cancer | Health Technology |
LigoCyte Pharmaceuticals, Inc.
 LigoCyte Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Developed vaccines and monoclonal antibody therapeutics | Health Technology |
San Diego Cancer Center
 San Diego Cancer Center Miscellaneous Commercial ServicesCommercial Services Operates as cancer research institute | Commercial Services |
Sidney Kimmel Cancer Center
 Sidney Kimmel Cancer Center Medical/Nursing ServicesHealth Services Provides medical research services | Health Services |
HemaQuest Pharmaceuticals, Inc.
 HemaQuest Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule therapeutics | Health Technology |
CONNECT
CONNECT Miscellaneous Commercial ServicesCommercial Services Offers education, networking and recognitions services | Commercial Services |
Altair Therapeutics, Inc.
Altair Therapeutics, Inc. Medical DistributorsDistribution Services Discovers, develops and commercializes antisense drugs | Distribution Services |
La Jolla Playhouse, Inc.
 La Jolla Playhouse, Inc. Miscellaneous Commercial ServicesCommercial Services Provides educational opportunities | Commercial Services |
MMRGlobal, Inc.
 MMRGlobal, Inc. Information Technology ServicesTechnology Services Provides electronic document management and online personal health record and storage solutions | Technology Services |
IDEC Corp. (United States)
 IDEC Corp. (United States) Electrical ProductsProducer Manufacturing Manufactures and distributes control equipment and related products | Producer Manufacturing |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Life Sciences Foundation
 The Life Sciences Foundation Miscellaneous Commercial ServicesCommercial Services Engages in education and biotechnology information dissemination | Commercial Services |
Viracta Subsidiary, Inc.
Viracta Subsidiary, Inc. BiotechnologyHealth Technology Develops proprietary viral gene activation therapy to address cancers associated with the epstein-barr virus | Health Technology |
Viracta Therapeutics, Inc.
 Viracta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for virus-associated cancers | Health Technology |
